https://www.inhibikase.com/investors/sec-filings/quarterly-reports/rss Inhibikase Therapeutics, Inc. (IKT) - Quarterly Reports en-us https://d1io3yog0oux5.cloudfront.net/inhibikase/files/theme/images/logo-sm.png /investors Equisolve Investor Relations Suite https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-25-283169/0001193125-25-283169.pdf Fri, 14 Nov 25 16:56:36 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-25-283169/0001193125-25-283169.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-25-180899/0001193125-25-180899.pdf Thu, 14 Aug 25 17:17:53 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-25-180899/0001193125-25-180899.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-25-071635/0000950170-25-071635.pdf Wed, 14 May 25 17:30:12 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-25-071635/0000950170-25-071635.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-24-126766/0000950170-24-126766.pdf Thu, 14 Nov 24 08:31:29 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-24-126766/0000950170-24-126766.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-24-097022/0000950170-24-097022.pdf Wed, 14 Aug 24 16:36:55 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-24-097022/0000950170-24-097022.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-24-060579/0000950170-24-060579.pdf Wed, 15 May 24 17:10:21 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-24-060579/0000950170-24-060579.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-23-063713/0000950170-23-063713.pdf Tue, 14 Nov 23 17:28:29 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-23-063713/0000950170-23-063713.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-23-042389/0000950170-23-042389.pdf Mon, 14 Aug 23 16:16:31 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-23-042389/0000950170-23-042389.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-23-021974/0000950170-23-021974.pdf Mon, 15 May 23 08:05:06 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-23-021974/0000950170-23-021974.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-22-025011/0000950170-22-025011.pdf Mon, 14 Nov 22 17:41:41 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-22-025011/0000950170-22-025011.pdf